Guidelines for treating Type 2 diabetes, like the same American Diabetes Associations (ADAs), generally recommend that patients receive metformin, and if necessary, the addition of other medication(s) like: A dipeptidyl peptidase-4 (DPP-4) inhibitor like Januvia, A Glucagon-like peptide-1 (GLP-1) receptor agonists receptor agonist like Ozempic, A sodium glucose co-transporter 2 (SGLT-2) inhibitor like Invokana, and / or A thiazolidinediones (TZD) like pioglitazone
The clinical data consistently shows that patients who combine GLP-1 therapy with structured dietary modifications and regular physical activity achieve significantly better outcomes than those relying on medication alone
Why is it so important to avoid compounded or unapproved versions of Tirzepatide
Persistent weight gain over several months (more than 5% of body weight) despite adherence to dietary and lifestyle recommendations
Additionally, the findings reveal that DSIP-CBBBP crosses the blood-brain barrier more effectively than traditional peptides, potentially enhancing its efficacy in vivo
This information can support a more informed conversation with your provider about whether compounded semaglutide or tirzepatide might complement your existing lifestyle efforts
